Follow us on:

AZN

AstraZeneca plc Calquence granted US Breakthrough Therapy Designation

August 14, 2019

AstraZeneca plc Lynparza Phase III PAOLA-1 trial met primary endpoint

August 14, 2019

AstraZeneca PLC Tagrisso significantly improves overall survival

August 9, 2019

AstraZeneca PLC Lynparza Phase III PROfound trial in HRR

August 7, 2019

AstraZeneca PLC Forxiga label updated with positive cardiovascular outcomes

August 5, 2019

AstraZeneca PLC Update on US regulatory decision for Farxiga in type-1 diabetes

July 15, 2019

AstraZeneca PLC Imfinzi granted US Orphan Drug Designation for small cell lung cancer

July 12, 2019

AstraZeneca PLC Fasenra receives positive EU CHMP opinion

July 1, 2019

AstraZeneca PLC Imfinzi improves overall survival at interim analysis

June 27, 2019

AstraZeneca plc Lynparza approved in Japan for 1st-line maintenance therapy

June 19, 2019

AstraZeneca PLC Bevespi Aerosphere approved by the Japanese

June 19, 2019

AstraZeneca PLC Lynparza approved in the EU for 1st-line maintenance treatment

June 18, 2019

AstraZeneca PLC Calquence significantly prolonged the time patient live without disease progression

June 17, 2019

AstraZeneca Calquence Phase III ELEVATE-TN trial meets primary endpoint

June 6, 2019

AstraZeneca Plc Lynparza nearly doubled time patients lived with

June 3, 2019

AstraZeneca Plc Pooled analyses of the roxadustat global Phase III

May 10, 2019

AstraZeneca Plc Trastuzumab deruxtecan demonstrated clinically

May 8, 2019

AstraZeneca Plc Calquence Phase III ASCEND trial met primary endpoint

May 7, 2019

AstraZeneca PLC Qternmet XR approved in the US for type-2 diabetes

May 3, 2019

AstraZeneca Plc Lynparza receives positive EU CHMP opinion for 1st

April 29, 2019

News and Interview Alerts

Company Presentations

Serinus Energy Investor Presentation

Serinus Energy Summary Presentation June 2020

Savannah Resources

Amino Technologies Investor Presentation Highlights Year End Nov 2019

Caledonia Mining Corporation

Caledonia Mining Corporation plc April 2020 Investor Presentation

KRM22

KRM22 Investor Presentation March 2020 – Risk Management in Capital Markets

Q&As

Hardman & Co

Real Estate Credit Investments (RECI): Manager presentation and Q&A

5 March 2026

Chesnara Plc: A positive expansion in Benelux

26 February 2026

ICG Enterprise Trust – Doubling realisations: sustainability and impact

9 February 2026

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Green News

Drax Group plc

Drax appoints Daniel Peacock as Interim CFO during Frank Lemmink’s medical leave

5 March 2026

Drax Group

Drax Group Delivers Results Ahead of Expectations, Says Longspur Research

4 March 2026

Diversified Energy

Diversified Energy Delivers Strong FY25 Results With EBITDA Beat And New Acquisition, Tennyson Securities

4 March 2026

Thor Energy

Thor Energy reestablishes Board representation at EnviroCopper

3 March 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

BrokerTalk

Firering Strategic Minerals

Firering Strategic Minerals Strengthens Limeco Position with Fresh Funding – Shard Capital

5 August 2025

Arbuthnot Banking Group

Arbuthnot Banking Group Demonstrates Capital Discipline and Strategic Progress, Shore Capital Notes

24 July 2025

CyanConnode

CyanConnode: A Stronger Foundation and Growing Momentum – Highlights Panmure Liberum

23 July 2025

Synetics Plc

Synectics Maintains Strong Momentum with Promising FY25 Outlook – Shore Capital

22 July 2025

Funds

Real Estate Credit Investments (RECI): Manager presentation and Q&A

5 March 2026

Top ISA Investing Opportunities

7 Top Investment Trust ISA Opportunities 2026

3 March 2026

Fidelity

Fidelity Special Values January update – shares rise on improving UK growth narrative

2 March 2026

JPMorgan European Discovery Trust plc

European fund opportunities: monetary and fiscal stimulus supports JEDT’s outperformance

2 March 2026

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Syncona Limited (SYNC.L) Stock Analysis: Exploring a 110% Upside Potential in the Asset Management Sector

5 March 2026

Spire Healthcare Group PLC (SPI.L) Investor Outlook: Unlocking a 38.77% Potential Upside

5 March 2026

Sequoia Economic Infrastructure (SEQI.L) Stock Analysis: High Dividend Yield and Promising Upside

5 March 2026

Supermarket Income REIT PLC ORD (SUPR.L) Stock Analysis: A High Dividend Yield Amidst Modest Upside

5 March 2026

DiscoverIE Group PLC (DSCV.L) Stock Analysis: A 44.84% Potential Upside in the Dynamic World of Electronic Components

5 March 2026

AZN

AstraZeneca plc Calquence granted US Breakthrough Therapy Designation

August 14, 2019

AstraZeneca plc Lynparza Phase III PAOLA-1 trial met primary endpoint

August 14, 2019

AstraZeneca PLC Tagrisso significantly improves overall survival

August 9, 2019

AstraZeneca PLC Lynparza Phase III PROfound trial in HRR

August 7, 2019

AstraZeneca PLC Forxiga label updated with positive cardiovascular outcomes

August 5, 2019

AstraZeneca PLC Update on US regulatory decision for Farxiga in type-1 diabetes

July 15, 2019

AstraZeneca PLC Imfinzi granted US Orphan Drug Designation for small cell lung cancer

July 12, 2019

AstraZeneca PLC Fasenra receives positive EU CHMP opinion

July 1, 2019

AstraZeneca PLC Imfinzi improves overall survival at interim analysis

June 27, 2019

AstraZeneca plc Lynparza approved in Japan for 1st-line maintenance therapy

June 19, 2019

AstraZeneca PLC Bevespi Aerosphere approved by the Japanese

June 19, 2019

AstraZeneca PLC Lynparza approved in the EU for 1st-line maintenance treatment

June 18, 2019

AstraZeneca PLC Calquence significantly prolonged the time patient live without disease progression

June 17, 2019

AstraZeneca Calquence Phase III ELEVATE-TN trial meets primary endpoint

June 6, 2019

AstraZeneca Plc Lynparza nearly doubled time patients lived with

June 3, 2019

AstraZeneca Plc Pooled analyses of the roxadustat global Phase III

May 10, 2019

AstraZeneca Plc Trastuzumab deruxtecan demonstrated clinically

May 8, 2019

AstraZeneca Plc Calquence Phase III ASCEND trial met primary endpoint

May 7, 2019

AstraZeneca PLC Qternmet XR approved in the US for type-2 diabetes

May 3, 2019

AstraZeneca Plc Lynparza receives positive EU CHMP opinion for 1st

April 29, 2019

News and Interview Alerts

Company Presentations

Serinus Energy Investor Presentation

Serinus Energy Summary Presentation June 2020

Savannah Resources

Amino Technologies Investor Presentation Highlights Year End Nov 2019

Caledonia Mining Corporation

Caledonia Mining Corporation plc April 2020 Investor Presentation

KRM22

KRM22 Investor Presentation March 2020 – Risk Management in Capital Markets

Q&As

Hardman & Co

Real Estate Credit Investments (RECI): Manager presentation and Q&A

5 March 2026

Chesnara Plc: A positive expansion in Benelux

26 February 2026

ICG Enterprise Trust – Doubling realisations: sustainability and impact

9 February 2026

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Green News

Drax Group plc

Drax appoints Daniel Peacock as Interim CFO during Frank Lemmink’s medical leave

5 March 2026

Drax Group

Drax Group Delivers Results Ahead of Expectations, Says Longspur Research

4 March 2026

Diversified Energy

Diversified Energy Delivers Strong FY25 Results With EBITDA Beat And New Acquisition, Tennyson Securities

4 March 2026

Thor Energy

Thor Energy reestablishes Board representation at EnviroCopper

3 March 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest interviews

Broker Talk

Firering Strategic Minerals

Firering Strategic Minerals Strengthens Limeco Position with Fresh Funding – Shard Capital

5 August 2025

Arbuthnot Banking Group

Arbuthnot Banking Group Demonstrates Capital Discipline and Strategic Progress, Shore Capital Notes

24 July 2025

CyanConnode

CyanConnode: A Stronger Foundation and Growing Momentum – Highlights Panmure Liberum

23 July 2025

Synetics Plc

Synectics Maintains Strong Momentum with Promising FY25 Outlook – Shore Capital

22 July 2025

Funds

Real Estate Credit Investments (RECI): Manager presentation and Q&A

5 March 2026

Top ISA Investing Opportunities

7 Top Investment Trust ISA Opportunities 2026

3 March 2026

Fidelity

Fidelity Special Values January update – shares rise on improving UK growth narrative

2 March 2026

JPMorgan European Discovery Trust plc

European fund opportunities: monetary and fiscal stimulus supports JEDT’s outperformance

2 March 2026

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Syncona Limited (SYNC.L) Stock Analysis: Exploring a 110% Upside Potential in the Asset Management Sector

5 March 2026

Spire Healthcare Group PLC (SPI.L) Investor Outlook: Unlocking a 38.77% Potential Upside

5 March 2026

Sequoia Economic Infrastructure (SEQI.L) Stock Analysis: High Dividend Yield and Promising Upside

5 March 2026

Supermarket Income REIT PLC ORD (SUPR.L) Stock Analysis: A High Dividend Yield Amidst Modest Upside

5 March 2026

DiscoverIE Group PLC (DSCV.L) Stock Analysis: A 44.84% Potential Upside in the Dynamic World of Electronic Components

5 March 2026

AZN

Astrazeneca plc

AstraZeneca plc Calquence granted US Breakthrough Therapy Designation

14 August 2019

Astrazeneca plc

AstraZeneca plc Lynparza Phase III PAOLA-1 trial met primary endpoint

14 August 2019

Astrazeneca plc

AstraZeneca PLC Tagrisso significantly improves overall survival

9 August 2019

Astrazeneca plc

AstraZeneca PLC Lynparza Phase III PROfound trial in HRR

7 August 2019

Astrazeneca plc

AstraZeneca PLC Forxiga label updated with positive cardiovascular outcomes

5 August 2019

Astrazeneca plc

AstraZeneca PLC Update on US regulatory decision for Farxiga in type-1 diabetes

15 July 2019

Astrazeneca plc

AstraZeneca PLC Imfinzi granted US Orphan Drug Designation for small cell lung cancer

12 July 2019

Astrazeneca plc

AstraZeneca PLC Fasenra receives positive EU CHMP opinion

1 July 2019

Astrazeneca plc

AstraZeneca PLC Imfinzi improves overall survival at interim analysis

27 June 2019

Astrazeneca plc

AstraZeneca plc Lynparza approved in Japan for 1st-line maintenance therapy

19 June 2019

Astrazeneca plc

AstraZeneca PLC Bevespi Aerosphere approved by the Japanese

19 June 2019

Astrazeneca plc

AstraZeneca PLC Lynparza approved in the EU for 1st-line maintenance treatment

18 June 2019

Astrazeneca plc

AstraZeneca PLC Calquence significantly prolonged the time patient live without disease progression

17 June 2019

Astrazeneca plc

AstraZeneca Calquence Phase III ELEVATE-TN trial meets primary endpoint

6 June 2019

Astrazeneca plc

AstraZeneca Plc Lynparza nearly doubled time patients lived with

3 June 2019

Astrazeneca plc

AstraZeneca Plc Pooled analyses of the roxadustat global Phase III

10 May 2019

Astrazeneca plc

AstraZeneca Plc Trastuzumab deruxtecan demonstrated clinically

8 May 2019

Astrazeneca plc

AstraZeneca Plc Calquence Phase III ASCEND trial met primary endpoint

7 May 2019

Astrazeneca plc

AstraZeneca PLC Qternmet XR approved in the US for type-2 diabetes

3 May 2019

Astrazeneca plc

AstraZeneca Plc Lynparza receives positive EU CHMP opinion for 1st

29 April 2019

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Company Presentations

Serinus Energy Investor Presentation

Serinus Energy Summary Presentation June 2020

15 June 2020

Savannah Resources

Amino Technologies Investor Presentation Highlights Year End Nov 2019

28 April 2020

Caledonia Mining Corporation

Caledonia Mining Corporation plc April 2020 Investor Presentation

24 April 2020

KRM22

KRM22 Investor Presentation March 2020 – Risk Management in Capital Markets

11 March 2020

Q&As

Hardman & Co

Real Estate Credit Investments (RECI): Manager presentation and Q&A

5 March 2026

Chesnara Plc: A positive expansion in Benelux

26 February 2026

ICG Enterprise Trust – Doubling realisations: sustainability and impact

9 February 2026

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

BrokerTalk

Firering Strategic Minerals

Firering Strategic Minerals Strengthens Limeco Position with Fresh Funding – Shard Capital

5 August 2025

Arbuthnot Banking Group

Arbuthnot Banking Group Demonstrates Capital Discipline and Strategic Progress, Shore Capital Notes

24 July 2025

CyanConnode

CyanConnode: A Stronger Foundation and Growing Momentum – Highlights Panmure Liberum

23 July 2025

Synetics Plc

Synectics Maintains Strong Momentum with Promising FY25 Outlook – Shore Capital

22 July 2025

FTSE 100

Funds

Real Estate Credit Investments (RECI): Manager presentation and Q&A

5 March 2026

Top ISA Investing Opportunities

7 Top Investment Trust ISA Opportunities 2026

3 March 2026

Fidelity

Fidelity Special Values January update – shares rise on improving UK growth narrative

2 March 2026

JPMorgan European Discovery Trust plc

European fund opportunities: monetary and fiscal stimulus supports JEDT’s outperformance

2 March 2026

View all Funds, Market Insights and news >>

Green News

Drax Group plc

Drax appoints Daniel Peacock as Interim CFO during Frank Lemmink’s medical leave

5 March 2026

Drax Group

Drax Group Delivers Results Ahead of Expectations, Says Longspur Research

4 March 2026

Diversified Energy

Diversified Energy Delivers Strong FY25 Results With EBITDA Beat And New Acquisition, Tennyson Securities

4 March 2026

Thor Energy

Thor Energy reestablishes Board representation at EnviroCopper

3 March 2026

View all Sustainable sectors, Plcs and news >>

UK Broker Ratings

Syncona Limited (SYNC.L) Stock Analysis: Exploring a 110% Upside Potential in the Asset Management Sector

5 March 2026

Spire Healthcare Group PLC (SPI.L) Investor Outlook: Unlocking a 38.77% Potential Upside

5 March 2026

Sequoia Economic Infrastructure (SEQI.L) Stock Analysis: High Dividend Yield and Promising Upside

5 March 2026

Supermarket Income REIT PLC ORD (SUPR.L) Stock Analysis: A High Dividend Yield Amidst Modest Upside

5 March 2026

DiscoverIE Group PLC (DSCV.L) Stock Analysis: A 44.84% Potential Upside in the Dynamic World of Electronic Components

5 March 2026